AbCellera Results Presentation Deck

Q3 2021 BUSINESS UPDATE COPYRIGHT © ABCELLERA 9 CREATING VALUE WITH BISPECIFICS OrthoMab™ bispecific engineering platform, coupled with our discovery engine, provides partners with a rapid and complete solution. for generating tailored, stable, and developable bispecific antibodies. H

View entire presentation